Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells

Toxicology Letters

Volumn 211, Issue 3, 2012, Pages 257-265

  Yoshioka, Hiroki ^a   Hiromori, Youhei ^a   Aoki, Akira ^a   Kimura, Tomoki ^b   Fujii Kuriyama, Yoshiaki ^c   Nagase, Hisamitsu ^a   Nakanishi, Tsuyoshi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

3 Methylcholanthrene (3MC); Aryl hydrocarbon receptor (AhR); Dioxin; Estrogen receptor (ER); Polychlorinated biphenyl (PCB); Real Time Cell Analyzer

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TRANSACTIVATION; WESTERN BLOTTING;

ACTINS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA PRIMERS; DNA, COMPLEMENTARY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HELA CELLS; HUMANS; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RNA INTERFERENCE; TETRACHLORODIBENZODIOXIN; THYMIDINE; TRANSFECTION;

EID: 84860296339     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.04.005     Document Type: Article

References (50)

1. Abdelrahim M., Ariazi E., Kim K., Khan S., Barhoumi R., Burghardt R., Liu S., Hill D., Finnell R., Wlodarczyk B., Jordan V.C., Safe S. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor α. Cancer Research 2006, 66:2459-2467.
2. Abdelrahim M., Smith R., Safe S. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Molecular Pharmacology 2003, 63:1373-1381.
3. Biegel L., Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 1990, 37:725-732.
4. Bock K.W., Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochemical Pharmacology 2006, 72:393-404.
5. Cummings A.M., Metcalf J.L., Birnbaum L. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. Toxicology and Applied Pharmacology 1996, 138:131-139.
6. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicology and Applied Pharmacology 1996, 140:173-179.
7. Fernandez P., Burghardt R., Smith R., Nodland K., Safe S. High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness. European Journal of Pharmacology 1994, 270:53-65.
8. Fernandez P., Safe S. Growth inhibitory and antimitogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells. Toxicology Letters 1992, 61:185-197.
9. Fu H.J., Jia L.T., Bao W., Zhao J., Meng Y.L., Wang C.J., Yao L.B., Chen S.Y., Yang A.G. Stable knockdown of estrogen receptor α by vector-based RNA interference suppresses proliferation and enhances apoptosis in breast cancer cells. Cancer Biology and Therapy 2006, 5:842-847.
10. Gierthy J.F., Bennett J.A., Bradley L.M., Cutler D.S. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Research 1993, 53:3149-3153.
11. Gierthy J.F., Lincoln D.W. Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Research and Treatment 1988, 12:227-233.
12. Gierthy J.F., Lincoln D.W., Gillespie M.B., Seeger J.I., Martinez H.L., Dickerman H.W., Kumar S.A. Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Research 1987, 47:6198-6203.
13. Harper N., Wang X., Liu H., Safe S. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Molecular and Cellular Endocrinology 1994, 104:47-55.
14. Hoffman E.C., Reyes H., Chu F.F., Sander F., Conley L.H., Brooks B.A., Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991, 252:954-958.
15. Holcomb M., Safe S. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Letters 1994, 82:43-47.
16. Ishimura R., Ohsako S., Kawakami T., Sakaue M., Aoki Y., Tohyama C. Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed rats. Toxicology and Applied Pharmacology 2002, 185:197-206.
17. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:9721-9726.
18. Kimura S., Gonzalez F.J., Nebert D.W. Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues. Molecular and Cellular Biology 1986, 6:1471-1477.
19. Kinoshita K., Kikuchi Y., Sasakura Y., Suzuki M., Fujii-Kuriyama Y., Sogawa K. Altered DNA binding specificity of Arnt by selection of partner bHLH-PAS proteins. Nucleic Acids Research 2004, 32:3169-3179.
20. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., Kalnins R.P., Frauson L.E., Park C.N., Barnard S.D., Hummel R.A., Humiston C.G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicology and Applied Pharmacology 1978, 46:279-303.
21. Koliopanus A., Kleeff J., Xiao Y., Safe S., Zimmerman A., Buchler M.W., Friess H. Increased aryl hydrocarbon receptor expression offers a potential therapeutic target in pancreatic cancer. Oncogene 2002, 21:6059-6070.
22. Krishnan V., Porter W., Santostefano M., Wang X., Safe S. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Molecular and Cellular Biology 1995, 15:6710-6719.
23. Krishnan V., Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicology and Applied Pharmacology 1993, 120:55-61.
24. Kuske B., Naughton C., Moore K., Macleod K.G., Miller W.R., Clarke R., Langdon S.P., Cameron D.A. Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models. Endocrine-related Cancer 2006, 13:1121-1133.
25. Lew B.J., Collins L.L., O'Reilly M.A., Lawrence B.P. Activation of the aryl hydrocarbon receptor during different critical windows in pregnancy alters mammary epithelial cell proliferation and differentiation. Toxicological Sciences 2009, 111:151-162.
26. Liu H., Biegel L., Narasimhan T.R., Rowlands C., Safe S. Inhibition of insulin-like growth factor-I responses in MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Molecular and Cellular Endocrinology 1992, 87:19-28.
27. Liu H., Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on insulin-induced responses in MCF-7 human breast cancer cells. Toxicology and Applied Pharmacology 1996, 138:242-250.
28. Loaiza-Perez A.I., Kenney S., Boswell J., Hollingshead M., Alley M.C., Hose C., Ciolino H.P., Yeh G.C., Trepel J.B., Vistica D.T., Sausville E.A. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Molecular Cancer Therapeutics 2004, 3:715-725.
29. Matthews J., Gustafsson J.A. Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucleic Receptor Signal 2006, 4:e016.
30. McDougal A., Wormke M., Calvin J., Safe S. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective Ah receptor modulator. Cancer Research 2001, 61:3901-3907.
31. Moore M., Wang X., Lu Y.F., Wormke M., Craig A., Gerlach J.H., Burghardt R., Barhoumi R., Safe S. Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone. Journal of Biological Chemistry 1994, 269:11751-11759.
32. Morrow D., Qin C., Smith R., Safe S. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation. Journal of Steroid Biochemistry and Molecular Biology 2004, 88:27-36.
33. Nakanishi T., Hiromori Y., Yokoyama H., Koyanagi M., Itoh N., Nishikawa J., Tanaka K. Organotin compounds enhance 17β-hydroxysteroid dehydrogenase type I activity in human choriocarcinoma JAr cells: potential promotion of 17β-estradiol biosynthesis in human placenta. Biochemical Pharmacology 2006, 71:1349-1357.
34. Nakanishi T., Kohroki J., Suzuki S., Ishizaki J., Hiromori Y., Takasuga S., Itoh N., Watanabe Y., Utoguchi N., Tanaka K. Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells. Journal of Clinical Endocrinology and Metabolism 2002, 87:2830-2837.
35. Nakanishi T., Nishikawa J., Hiromori Y., Yokoyama H., Koyanagi M., Takasuga S., Ishizaki J., Watanabe M., Isa S., Utoguchi N., Itoh N., Kohno Y., Nishihara T., Tanaka K. Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions. Molecular Endocrinology 2005, 19:2502-2516.
36. Oenga G.N., Spink D.C., Carpenter D.O. TCDD and PCBs inhibit breast cancer cell proliferation in vitro. Toxicological In Vitro 2004, 18:811-819.
37. Ohtake F., Baba A., Takada I., Okada M., Iwasaki K., Miki H., Takahashi S., Kouzmenko A., Nohara K., Chiba T., Fujii-Kuriyama Y., Kato S. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007, 446:562-566.
38. Ohtake F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., Tohyama C., Krust A., Mimura J., Chambon P., Yanagisawa J., Fujii-Kuriyama Y., Kato S. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003, 423:545-550.
39. Okey A.B. An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. Toxicological Sciences 2007, 98:5-38.
40. Petroff B.K., Mizinga K.M. Pharmacokinetics of ovarian steroids in Sprague-Dawley rats after acute exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). Reproductive Biology 2003, 3:131-141.
41. Puga A., Barnes S.J., Dalton T.P., Chang C., Knudsen E.S., Maier M.A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. Journal of Biological Chemistry 2000, 275:2943-2950.
42. Ramamoorthy K., Gupta M.S., Sun G., McDougal A., Safe S.H. 3,3',4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells. Carcinogenesis 1999, 20:115-123.
43. Safe S., Wormke M., Samudio I. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. Journal of Mammary Gland Biology and Neoplasia 2000, 5:295-306.
44. Safe S.H. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacology & Therapeutics 1995, 67:247-281.
45. Ström A., Hartman J., Foster J.S., Kietz S., Wimalasena J., Gustafsson J.A. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:1566-1571.
46. Wang W.L., Porter W., Burghardt R., Safe S.H. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 1997, 18:925-933.
47. Wormke M., Castro-Rivera E., Chen I., Safe S. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. Journal of Steroid Biochemistry and Molecular Biology 2000, 72:197-207.
48. Wormke M., Stoner M., Saville B., Walker K., Abdelrahim M., Burghardt R., Safe S. The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes. Molecular and Cellular Biology 2003, 23:1843-1855.
49. Zacharewski T.R., Bondy K.L., McDonell P., Wu Z.F. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Research 1994, 54:2707-2713.
50. Zhang S., Lei P., Liu X., Li X., Walker K., Kotha L., Rowlands C., Safe S. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. Endocrine-related Cancer 2009, 16:835-844.